These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18070842)

  • 1. Risk factors for and correlates of poststroke depression following discontinuation of antidepressants.
    Fiedorowicz JG; Takezawa K; Robinson RG
    J Neuropsychiatry Clin Neurosci; 2007; 19(4):399-405. PubMed ID: 18070842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up.
    Narushima K; Kosier JT; Robinson RG
    J Nerv Ment Dis; 2002 May; 190(5):296-303. PubMed ID: 12011609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study.
    Robinson RG; Schultz SK; Castillo C; Kopel T; Kosier JT; Newman RM; Curdue K; Petracca G; Starkstein SE
    Am J Psychiatry; 2000 Mar; 157(3):351-9. PubMed ID: 10698809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of antidepressants on the course of disability following stroke.
    Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
    Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression.
    Chan KL; Campayo A; Moser DJ; Arndt S; Robinson RG
    Arch Phys Med Rehabil; 2006 Jun; 87(6):793-8. PubMed ID: 16731214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poststroke depression.
    Franco K; Malhotra S
    Am J Psychiatry; 2001 Apr; 158(4):658-60. PubMed ID: 11282720
    [No Abstract]   [Full Text] [Related]  

  • 8. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression.
    Narushima K; Chan KL; Kosier JT; Robinson RG
    Am J Psychiatry; 2003 Jun; 160(6):1157-62. PubMed ID: 12777275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study.
    Chemerinski E; Robinson RG; Arndt S; Kosier JT
    J Nerv Ment Dis; 2001 Jul; 189(7):421-5. PubMed ID: 11504318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A; Fouilloux C; Ortiz S
    Proc West Pharmacol Soc; 2002; 45():154-5. PubMed ID: 12434564
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
    Gendall KA; Joyce PR; Mulder RT; Luty SE
    J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials.
    Kimura M; Tateno A; Robinson RG
    Am J Geriatr Psychiatry; 2003; 11(3):320-7. PubMed ID: 12724111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression and cerebrovascular disease.
    Robinson RG; Morris PL; Fedoroff JP
    J Clin Psychiatry; 1990 Jul; 51 Suppl():26-31; discussion 32-3. PubMed ID: 2195010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender.
    Joyce PR; Mulder RT; Luty SE; McKenzie JM; Rae AM
    Acta Psychiatr Scand; 2003 Jul; 108(1):20-3. PubMed ID: 12807373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement.
    Stassen HH; Angst J; Delini-Stula A
    Pharmacopsychiatry; 1999 Mar; 32(2):56-60. PubMed ID: 10333163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine (prozac) in depresion of adults.
    Kocur J; Rydzynski Z; Duszyk S; Gruszczynski W; Trendak W
    Homeost Health Dis; 1991; 33(5-6):295. PubMed ID: 18265505
    [No Abstract]   [Full Text] [Related]  

  • 19. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eighteen months of drug treatment for depression: predicting relapse and recovery.
    Mulder RT; Frampton CM; Luty SE; Joyce PR
    J Affect Disord; 2009 Apr; 114(1-3):263-70. PubMed ID: 18805590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.